Asian perspectives on the recognition and management of levodopa ‘wearing-off’ in Parkinson’s disease-Reference-Cited by-同舟云学术

Asian perspectives on the recognition and management of levodopa ‘wearing-off’ in Parkinson’s disease

Published:2015-09-21 Issue:11 Volume:15 Page:1285-1297
ISSN:1473-7175
Container-title:Expert Review of Neurotherapeutics
language:en
Short-container-title:Expert Review of Neurotherapeutics

Author:

Bhidayasiri Roongroj,Hattori Nobutaka,Jeon Beomseok,Chen Rou-Shayn,Lee Moon Keen,Bajwa Jawad A,Mok Vincent CT,Zhang Baorong,Syamsudin Thamrin,Tan Louis Chew Seng,Jamora Roland Dominic G,Pisarnpong Apichart,Poewe Werner

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Clinical Neurology,General Neuroscience

Link

http://www.tandfonline.com/doi/pdf/10.1586/14737175.2015.1088783

Reference95 articles.

1. Clinical spectrum of levodopa-induced complications

2. An algorithm (decision tree) for the management of Parkinson's disease (2001):: Treatment

3. Practice Parameter: Treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): [RETIRED]

4. Identification of motor and nonmotor wearing-off in Parkinson's disease: Comparison of a patient questionnaire versus a clinician assessment

5. The levodopa wearing-off phenomenon in Parkinson’s disease: pharmacokinetic considerations

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Wellness Prescription for Parkinson's: Mid to Late-Stage Disease;The American Journal of Geriatric Psychiatry;2023-09

2. Movement disorders in Indochina: Resource challenges and future solutions;Journal of Neural Transmission;2023-06-12

3. Safinamide as an Adjunct to Levodopa in Asian and Caucasian Patients With Parkinson’s Disease and Motor Fluctuations: A Post Hoc Analysis of the SETTLE Study;Journal of Movement Disorders;2023-05-31

4. Opicapone, a Novel Catechol-O-methyl Transferase Inhibitor, for Treatment of Parkinson’s Disease “Off” Episodes;Health Psychology Research;2022-06-28

5. Challenges of Parkinson’s Disease Care in Southeast Asia;NeuroPsychopharmacotherapy;2022